Şunu aradınız:: hypercholesterolémiou (Slovakça - İngilizce)

statíny sú voliteľným produktom pre liečbu pacientov s izolovanou hypercholesterolémiou.
statins are the products of choice to treat patients with isolated hypercholesterolemia.

dávkovanie atorvastatínu u pacientov s homozygotnou familiárnou hypercholesterolémiou je 10 až 80 mg denne.
systemic exposure was 6- to 11-fold higher based on auc(0-24).

liek pelzont bol skúmaný v štyroch hlavných štúdiách u pacientov s hypercholesterolémiou alebo zmiešanou dyslipidémiou.
pelzont was studied in four main studies in patients with hypercholesterolaemia or mixed dyslipidaemia.

bezpečnosť a účinnosť repathy u pediatrických pacientov s primárnou hypercholesterolémiou a zmiešanou dyslipidémiou neboli stanovené.
the safety and effectiveness of repatha in paediatric patients with primary hypercholesterolaemia and mixed dyslipidaemia has not been established.

liek trevaclyn sa skúmal v štyroch hlavných štúdiách v prípade pacientov s hypercholesterolémiou alebo so zmiešanou dyslipidémiou.
trevaclyn was studied in four main studies in patients with hypercholesterolaemia or mixed dyslipidaemia.

do štúdie taussig bolo zaradených spolu 102 pacientov so závažnou familiárnou hypercholesterolémiou a 96 pacientov s homozygotnou familiárnou hypercholesterolémiou.
a total of 102 severe familial hypercholesterolaemia patients and 96 homozygous familial hypercholesterolaemia patients enrolled in taussig.

pelzont sa používa ako doplnok k diéte alebo cvičeniu u dospelých pacientov s primárnou hypercholesterolémiou alebo zmiešanou dyslipidémiou:
pelzont is used in addition to diet and exercise in adult patients with primary hypercholesterolaemia or mixed dyslipidaemia:

do klinických štúdií bolo zaradených štrnásť pacientov vo veku ≥ 12 až < 18 rokov s homozygotnou familiárnou hypercholesterolémiou.
fourteen patients aged ≥ 12 to < 18 years with homozygous familial hypercholesterolaemia were included in clinical studies.

do klinických skúšaní bolo zaradených štrnásť dospievajúcich pacientov vo veku ≥ 12 až < 18 rokov s homozygotnou familiárnou hypercholesterolémiou.
fourteen adolescent patients aged ≥ 12 to < 18 years with homozygous familial hypercholesterolaemia have been included in clinical trials.

tieto výsledky sa zistili u pacientov s heterozygotnou familiárnou hypercholesterolémiou, nefamiliárnymi formami hypercholesterolémie a zmiešanými hyperlipidémiami vrátane pacientov s diabetes mellitus nezávislým na inzulíne.
178 vs 247

atorvastatín účinne znižuje hladiny ldl- cholesterolu u pacientov s homozygotnou familiárnou hypercholesterolémiou, čo je populácia, ktorá obvykle nereaguje na hypolipidemickú liečbu.
if these levels are found to be significantly elevated (> 5 times uln), treatment should be stopped. − if muscular symptoms are severe and cause daily discomfort, even if the cpk levels are elevated to ≤ 5 x uln, treatment discontinuation should be considered. − if symptoms resolve and cpk levels return to normal, then re-introduction of atorvastatin or introduction of an alternative statin may be considered at the lowest dose and with close monitoring. − atorvastatin must be discontinued if clinically significant elevation of cpk levels (> 10 x uln) occur, or if rhabdomyolysis is diagnosed or suspected.

liek cholestagel sa porovnával s placebom (zdanlivým liekom) v siedmych hlavných štúdiách, na ktorých sa zúčastnili dospelé osoby s primárnou hypercholesterolémiou.
cholestagel has been compared with placebo (a dummy treatment) in seven main studies involving adults with primary hypercholesterolaemia.

10 statíny dnes predstavujú primárnu voľbu u pacientov trpiacich hypercholesterolémiou pre vynikajúce schopnosti lipoproteínov s nízkou hustotou (ldl) znižovať cholesterol a pre dokázaný kladný výsledok liečby.
due to the increased risk of muscular disorders, combined use of gemfibrozil and statins is no longer chmp/ 1268/ 04

liek trevaclyn sa používa okrem diéty a cvičenia v prípade pacientov s dyslipidémiou (abnormálne vysoká hladina tuku v krvi), najmä s kombinovanou zmiešanou dyslipidémiou a primárnou hypercholesterolémiou.
trevaclyn is used in addition to diet and exercise in patients with dyslipidaemia (abnormally high levels of fat in the blood), particularly ‘combined mixed dyslipidaemia’ and ‘primary hypercholesterolaemia’.

kombinovaná antiretrovírusová liečba bola spojená s metabolickými abnormalitami ako napr. hypertriglyceridémiou, hypercholesterolémiou, inzulínovou rezistenciou, hyperglykémiou a hyperlaktatémiou (pozri časť 4. 4).
combination antiretroviral therapy has been associated with metabolic abnormalities such as hypertriglyceridaemia, hypercholesterolaemia, insulin resistance, hyperglycaemia and hyperlactataemia (see section 4.4).

liek pelzont sa používa spolu s diétou a cvičením u pacientov s dyslipidémiou (abnormálne vysoké hladiny tuku v krvi), najmä „kombinovanou zmiešanou dyslipidémiou“ a „primárnou hypercholesterolémiou“.
pelzont is used in addition to diet and exercise in patients with dyslipidaemia (abnormally high levels of fat in the blood), particularly ‘combined mixed dyslipidaemia’ and ‘primary hypercholesterolaemia’.